Delivery Order SPE2DB20D3103-SPE2DB25FP1P0
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $80,412.48 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,470,416 units of the pharmaceutical product IPOL VIAL 5ML. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,802.00, is for the delivery of IPOL VIAL 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 7, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp is the prime...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of January 30, 2024. This delivery order is part of a larger, single-award indefinite delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4563752529 IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also been awarded an indefinite delivery contract (IDC) by DLA with a potential...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,163.64 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,094.96, is for the supply of IPOL VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of April 30, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,270.30, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed price, non-set-aside contract with a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,134.70 and a completion date of September 16, 2024. The contract is a Firm Fixed Price delivery order, which is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, which has a potential value of $2,134.70, is for the delivery of IPOL VIAL 5ML pharmaceutical products to support military treatment programs and facilities. The contract does not have a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IPOL VIAL 5ML, a medical product, with a ceiling value of $1,090.10 and a period of performance ending on July 1, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...